HUP0401760A3 - Stent, process for production thereof and its use for treating for restenosen and/or trombozen - Google Patents

Stent, process for production thereof and its use for treating for restenosen and/or trombozen

Info

Publication number
HUP0401760A3
HUP0401760A3 HU0401760A HUP0401760A HUP0401760A3 HU P0401760 A3 HUP0401760 A3 HU P0401760A3 HU 0401760 A HU0401760 A HU 0401760A HU P0401760 A HUP0401760 A HU P0401760A HU P0401760 A3 HUP0401760 A3 HU P0401760A3
Authority
HU
Hungary
Prior art keywords
trombozen
restenosen
stent
treating
production
Prior art date
Application number
HU0401760A
Other languages
English (en)
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of HUP0401760A2 publication Critical patent/HUP0401760A2/hu
Publication of HUP0401760A3 publication Critical patent/HUP0401760A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/04—Use of organic materials, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
HU0401760A 2001-10-24 2002-10-11 Stent, process for production thereof and its use for treating for restenosen and/or trombozen HUP0401760A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10152460A DE10152460A1 (de) 2001-10-24 2001-10-24 Stents
PCT/EP2002/011402 WO2003035133A1 (de) 2001-10-24 2002-10-11 Stents

Publications (2)

Publication Number Publication Date
HUP0401760A2 HUP0401760A2 (hu) 2004-12-28
HUP0401760A3 true HUP0401760A3 (en) 2008-04-28

Family

ID=7703557

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0401760A HUP0401760A3 (en) 2001-10-24 2002-10-11 Stent, process for production thereof and its use for treating for restenosen and/or trombozen

Country Status (22)

Country Link
US (1) US20050064006A1 (hu)
EP (1) EP1439869A1 (hu)
JP (1) JP2005506151A (hu)
KR (1) KR20040074977A (hu)
CN (1) CN1575189A (hu)
AU (1) AU2002340549B2 (hu)
BR (1) BR0213481A (hu)
CA (1) CA2464290A1 (hu)
DE (1) DE10152460A1 (hu)
EC (1) ECSP045075A (hu)
EE (1) EE200400080A (hu)
HR (1) HRP20040456A2 (hu)
HU (1) HUP0401760A3 (hu)
IL (1) IL161445A0 (hu)
MA (1) MA26341A1 (hu)
MX (1) MXPA04003755A (hu)
NO (1) NO20041984L (hu)
NZ (1) NZ532443A (hu)
PL (1) PL367968A1 (hu)
RU (1) RU2004115757A (hu)
WO (1) WO2003035133A1 (hu)
ZA (1) ZA200402989B (hu)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
DE10129725A1 (de) * 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
DE10355461A1 (de) * 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005045518A1 (de) * 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
BRPI0616801B8 (pt) 2005-10-04 2021-05-25 Bayer Healthcare Ag "forma polimórfica de 5-cloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2-tiofenocarboxamida, seus processos de preparação e seus usos, medicamento, e processo para prevenção de coagulação de sangue in vitro
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
DE102005047558A1 (de) * 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
US20070097252A1 (en) * 2005-10-31 2007-05-03 Silverstein D A Imaging methods, cameras, projectors, and articles of manufacture
DE102006034916A1 (de) * 2006-07-28 2008-01-31 Bayer Healthcare Ag Beschichtung künstlicher Oberflächen von medizinischen Hilfsmitteln und Geräten sowie Reinigung und/oder Vorbehandlung von Kathetern und anderen medizinischen Hilfsmitteln und Geräten
DE102006051625A1 (de) * 2006-11-02 2008-05-08 Bayer Materialscience Ag Kombinationstherapie substituierter Oxazolidinone
US8741890B2 (en) * 2007-11-15 2014-06-03 Boehringer Ingelheim International Gmbh Substituted amides, manufacturing and use thereof as medicaments
US11654036B2 (en) 2020-05-26 2023-05-23 Elixir Medical Corporation Anticoagulant compounds and methods and devices for their use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2134870T3 (es) * 1993-05-01 1999-10-16 Merck Patent Gmbh Antagonistas del receptor de adhesion.
US6133256A (en) * 1997-04-14 2000-10-17 Cor Therapeutics Inc Selective factor Xa inhibitors
US6273913B1 (en) * 1997-04-18 2001-08-14 Cordis Corporation Modified stent useful for delivery of drugs along stent strut
US20010029351A1 (en) * 1998-04-16 2001-10-11 Robert Falotico Drug combinations and delivery devices for the prevention and treatment of vascular disease
DE19962924A1 (de) * 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
DE10105989A1 (de) * 2001-02-09 2002-08-14 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung

Also Published As

Publication number Publication date
HUP0401760A2 (hu) 2004-12-28
PL367968A1 (en) 2005-03-07
NZ532443A (en) 2005-11-25
JP2005506151A (ja) 2005-03-03
EE200400080A (et) 2004-08-16
EP1439869A1 (de) 2004-07-28
IL161445A0 (en) 2004-09-27
ZA200402989B (en) 2005-04-20
HRP20040456A2 (en) 2005-06-30
RU2004115757A (ru) 2005-04-10
KR20040074977A (ko) 2004-08-26
NO20041984L (no) 2004-05-13
CN1575189A (zh) 2005-02-02
ECSP045075A (es) 2004-05-28
MXPA04003755A (es) 2004-07-23
AU2002340549B2 (en) 2007-11-29
US20050064006A1 (en) 2005-03-24
WO2003035133A1 (de) 2003-05-01
DE10152460A1 (de) 2003-05-08
CA2464290A1 (en) 2003-05-01
MA26341A1 (fr) 2004-10-01
BR0213481A (pt) 2004-11-03

Similar Documents

Publication Publication Date Title
TWI315741B (en) A-isomaltosyltransferase, process for producing the same and use thereof
AU2003257604A8 (en) Stent and process for producing the same
AU2002211708A1 (en) Apparatus, methods and articles of manufacture for executing computerized transaction processes
EP1565644A4 (en) METHOD AND SYSTEM FOR TREATING DRILLING HOLES
HK1046681B (zh) 6-鏈烯基-、6-鏈炔基-和6-環氧-epothilone衍生物，它們的製備方法及用途
HUP0401279A3 (en) Polyurethane elastomers, method for the production thereof and their use
EP1419218A4 (en) METHOD FOR CONTINUOUS TREATMENT OF NAPHTHA
IL159839A (en) Pyrazolylcarboxanilides, process for their preparation and their use for controlling undesired microorganisms
MXPA03006677A (es) Proceso para tratar articulos de metales multiples.
GB0113078D0 (en) Process and plant
MXPA03009300A (es) Articulos absorbentes de tipo de calzoncillo y metodos para hacer tales articulos absorbentes.
HUP0401760A3 (en) Stent, process for production thereof and its use for treating for restenosen and/or trombozen
GB0129976D0 (en) Treatment method
IL161893A0 (en) 5-Phenylpyrimidines, agents comprising the same, method for production and use thereof
HK1064261A1 (en) Method for the treatment of tobacco.
MX240745B (es) Proceso de hidroprocesamiento.
MX227439B (es) Proceso de hidroprocesamiento.
AP2004003070A0 (en) The method of treating cancer.
GB0120147D0 (en) Treatment method
AU2002361375A8 (en) Method for treating cellulosic moulded bodies
AU6222901A (en) Cyclipostins, a method for their production and the use of the same
ZA200202527B (en) A method for the production of tannin and its use.
ZA200101058B (en) Process for the treatment of gases.
IL157793A0 (en) Caloporoside derivatives, methods for the production thereof and their use
IL151871A0 (en) Restenosis treatment

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT, DE

Free format text: FORMER OWNER(S): BAYER HEALTHCARE AG., DE

FD9A Lapse of provisional protection due to non-payment of fees